Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Uniqure turns the screw on Spark and Pfizer
EP Vantage
Fri, 02/8/19 - 11:37 am
Tags:
uniQure, Spark Therapeutics, Pfizer, AMT-061, hemophilia B
CEOs of Pfizer, Merck, Sanofi to testify in Senate drug pricing hearing
Biopharma Dive
Wed, 02/6/19 - 01:27 pm
Tags:
Pfizer, Sanofi, Merck, drug pricing, Senate
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Yahoo/Bloomberg
Wed, 02/6/19 - 09:51 am
Tags:
BioNTech, IPOs, Pfizer, Sanofi, vaccines, cancer vaccines
Powerful Senate committee invites pharma executives to testify
Reuters
Tue, 02/5/19 - 11:31 pm
Tags:
Senate, drug pricing, AbbVie, AstraZeneca, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Sanofi
Moderna’s Not the Only One: A Look at the mRNA Market
BioSpace
Mon, 02/4/19 - 09:55 am
Tags:
MRNA, Moderna Therapeutics, Pfizer, BioNTech, CureVac, Translate Bio
Pfizer's Next 3 Years: What Investors Can Expect
Motley Fool
Sun, 02/3/19 - 12:54 pm
Tags:
Pfizer, earnings
EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes
Business Insider
Sat, 02/2/19 - 12:41 pm
Tags:
EpiPens, Pfizer, Meridian Medical Technologies, FDA
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
Tags:
earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda
FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game
Endpoints
Thu, 01/31/19 - 11:27 am
Tags:
Merck, V114, vaccines, FDA, breakthrough status, Prevnar 13, Pfizer
Pfizer CEO: It'll be 2020 before issues in sterile injectables manufacturing are resolved
Fierce Pharma
Wed, 01/30/19 - 11:48 pm
Tags:
Pfizer, injectibles, drug manufacturing, drug shortages
Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial
Pharmaceutical Business Review
Wed, 01/30/19 - 10:05 am
Tags:
Pfizer, Eli Lilly, tanezumab, clinical trials, osteoarthritis pain, osteoarthritis
3 Big Pharmas Expecting a Softer 2019
Motley Fool
Wed, 01/30/19 - 09:50 am
Tags:
JNJ, AbbVie, Pfizer
Pfizer Q4 Earnings Update: 4 Key Things You Need to Know
Motley Fool
Tue, 01/29/19 - 03:41 pm
Tags:
Pfizer, earnings
As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?
Endpoints
Tue, 01/29/19 - 10:02 am
Tags:
Pfizer, Bavencio, R&D
Pfizer’s Cancer Portfolio Expected to Rake in $8.3 Billion in 2019
BioSpace
Mon, 01/28/19 - 10:44 pm
Tags:
Pfizer, oncology, cancer
Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters
Forbes
Mon, 01/28/19 - 11:00 am
Tags:
Big Pharma, Pfizer, Merck, AstraZeneca, Gilead Sciences, Alexion, Vertex Pharmaceuticals
3 Things You Should Expect in Pfizer's Q4 Earnings Update
Yahoo/Motley Fool
Sun, 01/27/19 - 11:55 am
Tags:
Pfizer, earnings
Pfizer launches China's first pay-for-performance model for cancer
BioCentury
Sat, 01/26/19 - 11:43 am
Tags:
Pfizer, China, breast cancer, palbociclib, pay-for-performance
Pfizer, Novartis, Amgen add to 2019 drug price hikes
Biopharma Dive
Fri, 01/25/19 - 11:03 pm
Tags:
drug pricing, Pfizer, Novartis, Amgen
Would Pfizer Shareholders Win With an Acquisition of Amarin?
Motley Fool
Sun, 01/20/19 - 03:26 pm
Tags:
Pfizer, Amarin, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.